Richard A. Miller M.D., President and CEO at Corvus Pharmaceuticals, Inc. (CRVS), bought 10,000 shares at $4.39 ($44K) on 2018-12-20, disclosed to the SEC on 2018-12-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.39 | 5,000 | $22K | 49.9% |
| 2 | $4.40 | 5,000 | $22K | 50.1% |
| Total | $4.39 avg | 10,000 | $44K | 100% |
| Filing → |
| CRVS | BUY | 2022-12-15 | $45K | — | Filing → |
| CRVS | BUY | 2022-09-28 | $19K | — | Filing → |
| CRVS | BUY | 2022-09-20 | $16K | — | Filing → |